Glucose Measurement

OTHER4 trials

Sponsors

Sheba Medical Center, Centre Hospitalier Universitaire, Amiens, Ohio State University Comprehensive Cancer Center, Mayo Clinic

Conditions

Clinical Stage IV Cutaneous Melanoma AJCC v8Diabetes MellitusFlap NecrosisGlioblastoma, IDH-WildtypeMetastatic Cutaneous MelanomaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8WHO Grade 4 Glioma

Unknown Phase

Comparison of Aqueous and Plasma Glucose Level in Diabetic Patients

Sheba Medical CenterDiabetes Mellitus

Start: 2016-05-31End: 2018-03-31Target: 25Updated: 2016-04-25

Monitoring of the Bone Free Flaps With Microdialysis

RecruitingNCT03935139

Centre Hospitalier Universitaire, AmiensFlap Necrosis

Start: 2019-07-22End: 2025-07-31Target: 40Updated: 2024-07-10

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

RecruitingNCT06391099

Ohio State University Comprehensive Cancer CenterClinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, Metastatic Renal Cell Carcinoma +1

Start: 2025-11-17End: 2027-12-31Target: 60Updated: 2026-03-19

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

RecruitingNCT07091864

Mayo ClinicGlioblastoma, IDH-Wildtype, WHO Grade 4 Glioma

Start: 2025-07-29End: 2027-11-30Target: 116Updated: 2025-11-10